Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 1/20 | 0.34 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.34 |
| ▸ | MARK3 | P27448 | 1/20 | 0.34 |
| ▸ | FLT4 | P35916 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | NEK2 | P51955 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | MARK2 | Q7KZI7 | 1/20 | 0.34 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.34 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12307189 | 0.89 | CHEK2 (0.35) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12307206 | 0.83 | PTGES (0.31) | — | |
| SCHEMBL16556957 | 0.82 | CHEK2 (0.31) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12307156 | 0.82 | PLK1 (0.40) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12335531 | 0.80 | CHEK2 (0.33) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12307019 | 0.77 | PLK1 (0.43) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12307211 | 0.75 | — | — | |
| SCHEMBL16556883 | 0.75 | CHEK2 (0.35) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12334515 | 0.73 | PLK1 (0.43) | CHEK2RPS6KB1MARK3FLT4KDR | |
| SCHEMBL12307168 | 0.73 | CHEK2 (0.32) | CHEK2RPS6KB1MARK3FLT4KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9424998-B2 | Dye, photoelectric conversion element using the same, photoelectrochemical cell, and method of producing dye | FUJIFILM CORPORATION (JP) | 2016-08-23 | — | — | US | disclosed |
| US-8779126-B2 | Dye, photoelectric conversion element using the same, photoelectrochemical cell, and method of producing dye | FUJIFILM CORPORATION (JP) | 2014-07-15 | — | — | US | disclosed |
| US-20110213144-A1 | DYE, PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME, PHOTOELECTROCHEMICAL CELL, AND METHOD OF PRODUCING DYE | FUJIFILM CORPORATION (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110213144-A1 | DYE, PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME, PHOTOELECTROCHEMICAL CELL, AND METHOD OF PRODUCING DYE | CYBA, SCN3A, CRY1 | CHEK2 2769/4885RPS6KB1 2931/4885MARK3 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.